Sarcomas
Sarcomas are a group of cancers that originate in the connective tissues of the body, including bones, muscles, and fat. They can occur in various forms and may present with different symptoms depending on their location.
NK Cell Infusion for Sarcoma in Young Patients
We are testing a new immunotherapy using activated NK cells for children, adolescents, and young adults with refractory sarcomas. The goal is to evaluate its safety and effects after chemotherapy or radiotherapy.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 0 and 40 years old?
- Do you have malignant sarcoma (a type of cancer)?
- Are you a woman who can become pregnant, and have you had a negative pregnancy test?
- Do you have a compatible donor, like a parent or sibling?
- Do you have any major emotional or psychological problems that affect your ability to participate?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Allogeneic Peripheral Blood-Derived CD56+ Natural Killer Cells
K562-mb15-41BBI Cell Line
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Hospital Universitario La Paz
Unidad de Hemato-Oncología Pediátrica
Chamartín, Spain
Sponsor: Hospital Universitario La Paz
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.